VA
MDLN

Vident Advisory’s Medline Inc MDLN Stock Holding History

Vident Advisory’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$496K Buy
+11,136
New +$492K ﹤0.01% 1263

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Vident Advisory's MDLN Position: Q1 2026 in Review

Vident Advisory opened a new position in Medline Inc (MDLN) in Q1 2026: 11,136 shares worth $496K. The stake represents ﹤0.01% of the portfolio and ranks #1263 among its holdings.

314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Vident Advisory held 11,136 shares of Medline Inc worth $496K as of Q1 2026.
  • Medline Inc was a new Vident Advisory position in Q1 2026.
  • Medline Inc made up ﹤0.01% of Vident Advisory's portfolio in Q1 2026, its #1263 holding.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.